Highlights
NASDAQ: RIGL       Rigel Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
2.46   +0.03 (1.23%)  2.34 - 2.49  6,801,700

Overview

 
Avg Volume (4 weeks):19,747,000
4 Weeks Range:1.77 - 5.24
4 Weeks Price Volatility (%):
19.88%
52 Weeks Range:1.23 - 5.24
52 Weeks Price Volatility (%):
30.67%
Average Price Target: 10.00
Price Target Upside/Downside: +7.54

Headlines



No recent Headlines for this stock.


Business Background

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken over all responsibility to develop and market the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes Fostamatinib - ITP, Fostamatinib - AIHA, Fostamatinib - IgAN, BGB324 - Oral AXL Inhibitor, ATI-50001 & 50002 - JAK Inhibitors, DS-3032-MDM2 Inhibitor, THF-beta Inhibitors and AZD0449- Inhaled JAK Inhibitor.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

5562  2668  556  154 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SRNE 12.84+3.07 
 AMD 85.04+7.37 
 NIO 13.64+0.04 
 ATHE 3.43+2.08 
 SLV 24.25+1.51 
 VALE 11.49+0.07 
 GE 6.14+0.03 
 F 6.86+0.17 
 SQQQ 5.62-0.075 
 KODK 14.40-0.54 
Partners & Brokers